Insiders · Profile

Lee Jennifer Kayden

EVP, Head of North America at RHYTHM PHARMACEUTICALS. Filing since 15 Feb 2022. CIK 0001801372

Company
Date
Role
Action
Shares
Amount
Of holding
13 Aug 2026
EVP, Head of North America
Sold on a plan
75,834
$8.90M
100%
19 Feb 2025
EVP, Head of North America
Sold on a plan
2,035
$116.44K
25.8%
13 Feb 2025
EVP, Head of North America
Sold on a plan
1,205
$69.89K
33.5%
12 Feb 2025
EVP, Head of North America
Sold on a plan
1,815
$102.35K
33.5%
11 Feb 2025
EVP, Head of North America
Sold on a plan
1,027
$59.06K
15.9%
10 Feb 2025
EVP, Head of North America
Sold on a plan
4,189
$246.78K
48.7%
5 Feb 2025
EVP, Head of North America
Sold on a plan
3,066
$185.64K
75.9%
4 Feb 2025
EVP, Head of North America
Sold at will
1,447
$86.00K
26.4%
11 Nov 2024
EVP, Head of North America
Sold on a plan
66,861
$4.43M
98.6%
20 Mar 2024
EVP, Head of North America
Sold at will
18,235
$707.00K
72.7%
19 Mar 2024
EVP, Head of North America
Sold at will
15,515
$608.50K
38.2%
13 Feb 2024
EVP, Head of North America
Sold at will
615
$30.65K
8.2%
12 Feb 2024
EVP, Head of North America
Sold at will
1,023
$52.56K
12.0%
1 Feb 2024
EVP, Head of North America
Sold at will
1,492
$67.23K
33.1%
14 Nov 2023
EVP, Head of North America
Sold on a plan
13,677
$437.82K
100%
9 Nov 2023
EVP, Head of North America
Sold on a plan
3,438
$95.18K
67.6%
8 Nov 2023
EVP, Head of North America
Sold on a plan
5,712
$165.10K
77.6%
3 Nov 2023
EVP, Head of North America
Sold on a plan
80
$2.24K
4.6%
5 Sep 2023
EVP, Head of North America
Sold on a plan
6,166
$172.96K
78.9%
9 Aug 2023
EVP, Head of North America
Sold on a plan
1,718
$42.37K
34.3%
7 Aug 2023
EVP, Head of North America
Sold on a plan
11,223
$271.35K
77.3%
14 Feb 2023
EVP, Head of North America
Sold, plan not stated
635
$17.06K
11.4%
9 Feb 2023
EVP, Head of North America
Sold, plan not stated
1,192
$32.97K
25.1%
15 Feb 2022
EVP, Head of North America
Sold, plan not stated
722
$4.40K
35.5%
24 decisions on file.